Genmab Publishes 2024 Annual Report

Seeking Alpha / 2 hours from now 1 Views

Company Announcement

Announcement of Dorado Marketing Agreement

4 hours from now
Genmab Files Annual Report with the U.S. Securities and Exchange Commission

4 hours from now
Weekly share repurchase program transaction details

4 hours from now
Red Cat Raises Up to $20 Million in Debt Financing

4 hours from now
MiNK Therapeutics to Present Updated Data from Phase 2 Study Testing AgenT-797 in Gastric Cancer at AACR IO Annual Meeting

4 hours from now